Atrius Health Central OB/GYN CME Presents: OB/GYN Clinical Educational Meeting, 6/1/22
Claiming Credit for Session
Thank you for attending Atrius Health's OB/GYN Clinical Meeting on June 1, 2022. Once logged in, please click on "Take Course" on the right-hand side and your enrollment will be recorded. You will be prompted to take an evaluation to claim your credit on the following page.
Educational Needs Addressed
In this meeting, Atrius Health discussed the new advances in guidelines and treatments as identified by their internal specialists and CME planning committee. The latest practice data and findings were discussed with the goal of further improving internal practice and treatments.
Atrius Health OB/GYN Clinicians
At the completion of this activity, pharmacists will be able to:
- Be able to collaborate with our new geneticist
- Utilize mifepristone for medical management of spontaneous abortions
- Implement new guidelines for managing hypertension in pregnancy
- Appropriately refer to pelvic floor physical therapist
- Align personal practice with departmental and organizational goals
- Obtain anal Paps and manage results; administer HPV vaccine to women over 26
- Deliver patient centered contraceptive care
Faculty Presenters and Disclosures
Martha Richardson, MD
Obstetrics and Gynecology
Harvard Vanguard Medical Associates
The Copley Center
Elizabeth Buechler, MD; Tayla Curran, DPT, MSC; Joel Krier MD; Deborah Platek MD; Lilja Stefannson, MD; and Kevin Fitzpatrick, MD of Atrius Health have no relevant financial relationships to disclose.
Katharine White, MD, MPH, of Partners in Contraceptive Choice and Knowledge (PICCK) discloses she receives grant/research support from Bayer, Evofem and Merck.
Planning Committee and Disclosures
Meghan Bride, NP; Erin Brooks, MD, Caroline Elich, RN; Deborah Platek, MD; Martha Richardson, MD; and Payal Srinivasas, MD, of Atrius Health have no relevant financial relationships to disclose.
The following planning committee members from Boston University School of Medicine’s Office of Continuing Medical Education have no relevant financial relationships with ineligible companies:
Michael Burk, BS – Operations Manager
Carmela A. Townsend, DNP, MS/MBA, RN – Lead Nurse Planner
Accreditor Disclosure Policy
Boston University School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.
In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships with ineligible companies that faculty, planners, authors and anyone who may be in control of content have been mitigated.
The faculty members do plan on discussing unlabeled/investigational uses of a commercial product. Dr. Elizabeth Buechler will discuss HPV testing from location other than the cervix.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and Atrius Health. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Boston University School of Medicine designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This educational activity has been provided by Boston University School of Medicine Continuing Nursing Education and jointly-provided by Atrius Health.
Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Contact Hours: 3.33 of which, 1.33 are eligible for pharmacology credit
This program includes 0.33 hours which meet the criteria of the Massachusetts Board of Registration in Medicine for risk management study.
- 0.00 ACPE Pharmacy
- 3.50 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 3.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 0.33 MA Risk Management
- 3.33 ANCC
- 1.33 ANCC Pharmacology
- 3.50 Participation